ACT Capital Partners, L.P.

WAYNE, PA · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 6, 2026 · Open the SEC source ↗
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$151.6M2026 Q3+ $2.4M options (notional, not included)
Positions58
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.64.6%

ACT Capital Partners, L.P. reported 58 positions worth $151.6M as of September 30, 2026 (13F filed November 6, 2026). Largest holding: CVX (9.9%).

10 / 58 positions shown
#SymbolCompanyValue ↓% Port.Shares1YYTDSince reported
▸ 1 CVXChevron$15.3M9.95%75,000——+6.3%
▸ 2 KRYSKrystal Biotech$14.0M9.07%42,000——-10.4%
▸ 3 TGTXTG Therapeutics$13.2M8.59%237,200——+15.7%
▸ 4 XOMExxonMobil$12.8M8.30%78,500——+2.5%
▸ 5 AMZNAmazon$10.6M6.88%42,500——+3.5%
▸ 6 ABVXAbivax S.A.$8.4M5.47%85,000———
▸ 7 VKTXViking Therapeutics$7.2M4.66%220,200——-17.6%
▸ 8 SKHYSK hynix$6.4M4.15%34,700———
▸ 9 ARWRArrowhead Pharmaceuticals$6.2M4.00%94,000——-32.5%
▸ 10 NKTRNektar Therapeutics$5.5M3.56%90,400——-38.4%

Pro Feature

The remaining 48 positions with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

🔔 Tell me when this fund files a new 13F

No account needed: in your inbox the morning it is published.

Frequently Asked Questions

What stocks does ACT Capital Partners, L.P. hold as of Q3 2026?

ACT Capital Partners, L.P. reported 58 positions worth $151.6M in its Q3 2026 13F filing. Largest positions: CVX (9.9%), KRYS (9.1%), TGTX (8.6%), XOM (8.3%) and AMZN (6.9%).

What did ACT Capital Partners, L.P. buy in Q3 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did ACT Capital Partners, L.P. sell in Q3 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.